Novo Nordisk | NVO - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
ANI Pharmaceuticals USD 1.69B 57M 2026-05
Aurora Cannabis CAD 327.21M 142.93M 2025-12
Bristol-Myers Squibb USD 123.83B 14.02B 2026-03
Canopy Growth CAD 656.46M 124.89M 2025-12
Corcept Therapeutics USD 4.32B 654M 2026-03
Drreddys Laboratories INR 11.69B 50M 2025-12
Eli Lilly USD 869.02B 146.97B 2026-03
GlaxoSmithKline GBP 83.8B 9.44B 2026-03
Merck USD 297.1B 35.84B 2026-03
Nektar Therapeutics USD 15.62B 14.76B 2026-05
Novartis USD 232.75B 75B 2026-05
Novo Nordisk A/S DKK 1.45T 421.31B 2026-05
Pacira USD 915M 149M 2026-03
Perrigo USD 1.58B 265M 2026-05
Phibro Animal Health USD 1.51B 126M 2025-12
Prestige Brands USD 2.57B 233M 2026-05
Sanofi EUR 100.27B 605.48M 2026-03
Supernus Pharmaceuticals USD 2.82B 155M 2026-05
Zoetis USD 39.98B 9.73B 2026-05